Advaxis, Inc.'s Dr. John Rothman to Present at the Biotechnology Industry Organization (BIO) International Convention in San Diego, CA

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Dr. John Rothman CEO of Advaxis Inc., (OTCBB: ADXS), a developmental biotechnology company, is scheduled to present at the BIO International Convention (BIO) today, Wednesday, June 18, 2008, at 1:00PM PDT in the GEN Theater. Dr. Rothman’s presentation, entitled “The Use Of Bioengineered Listeria Monocytogenes As A Live Cancer Vaccine,” will detail how modified live Listeria bacteria is being used as the vector to target cervical and prostate cancer.

Back to news